In addition to the recommended antimicrobials to treat (potentially) invasive Salmonella infections, we explored the in vitro susceptibility of the same set of isolates as described earlier against several alternative antimicrobials including gatifloxacin, meropenem, temocillin, tigecycline, colistin, and several combination agents containing beta-lactamase inhibitors, namely ceftazidime/avibactam, ceftolozane/tazobactam, meropenem/vaborbactam, piperacillin/tazobactam. Here, LACTB is linked to Salmonella Infections.